These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19015905)

  • 1. The cost of resistance: incremental cost of methicillin-resistant Staphylococcus aureus (MRSA) in German hospitals.
    Resch A; Wilke M; Fink C
    Eur J Health Econ; 2009 Jul; 10(3):287-97. PubMed ID: 19015905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment.
    Wernitz MH; Keck S; Swidsinski S; Schulz S; Veit SK
    Clin Microbiol Infect; 2005 Jun; 11(6):466-71. PubMed ID: 15882196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU: risk factors, morbidity and cost].
    Lepelletier D; Ferréol S; Villers D; Richet H
    Pathol Biol (Paris); 2004 Oct; 52(8):474-9. PubMed ID: 15465267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of an outbreak of meticillin-resistant Staphylococcus aureus.
    Kanerva M; Blom M; Tuominen U; Kolho E; Anttila VJ; Vaara M; Virolainen-Julkunen A; Lyytikäinen O
    J Hosp Infect; 2007 May; 66(1):22-8. PubMed ID: 17433492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of the meticillin-resistant Staphylococcus aureus search and destroy policy in a Dutch university hospital.
    Nulens E; Broex E; Ament A; Deurenberg RH; Smeets E; Scheres J; van Tiel FH; Gordts B; Stobberingh EE
    J Hosp Infect; 2008 Apr; 68(4):301-7. PubMed ID: 18353496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for cost reduction based on pre-admission MRSA screening in general surgery.
    Diller R; Sonntag AK; Mellmann A; Grevener K; Senninger N; Kipp F; Friedrich AW
    Int J Hyg Environ Health; 2008 Mar; 211(1-2):205-12. PubMed ID: 17692566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?
    Ben-David D; Novikov I; Mermel LA
    Infect Control Hosp Epidemiol; 2009 May; 30(5):453-60. PubMed ID: 19344266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
    Gould IM
    Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost and morbidity of MRSA in head and neck cancer patients: what are the consequences?
    Watters K; O'dwyer TP; Rowley H
    J Laryngol Otol; 2004 Sep; 118(9):694-9. PubMed ID: 15509366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Staphylococcus aureus infection in an acute geriatric unit].
    Gómez-Pavón J; Rodríguez Salazar J; Fernández de la Puente E; Baztán Cortés JJ; Ruipérez Cantera I; González I; Cortés Bohórquez R
    Rev Esp Geriatr Gerontol; 2010; 45(1):5-9. PubMed ID: 20044174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia.
    Lodise TP; McKinnon PS
    Diagn Microbiol Infect Dis; 2005 Jun; 52(2):113-22. PubMed ID: 15964499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which rate describes the MRSA situation appropriately?].
    Gastmeier P; Chaberny IF
    Dtsch Med Wochenschr; 2007 Jul; 132(27):1480-2. PubMed ID: 17583833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control.
    Gould IM; Reilly J; Bunyan D; Walker A
    Clin Microbiol Infect; 2010 Dec; 16(12):1721-8. PubMed ID: 20825434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada.
    Kirwin E; Varughese M; Waldner D; Simmonds K; Joffe AM; Smith S
    BMC Health Serv Res; 2019 Oct; 19(1):743. PubMed ID: 31651305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic and clinical impact of nosocomial meticillin-resistant Staphylococcus aureus infections in Singapore: a matched case-control study.
    Pada SK; Ding Y; Ling ML; Hsu LY; Earnest A; Lee TE; Yong HC; Jureen R; Fisher D
    J Hosp Infect; 2011 May; 78(1):36-40. PubMed ID: 21269733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia.
    Wang FD; Chen YY; Chen TL; Liu CY
    Am J Infect Control; 2008 Mar; 36(2):118-22. PubMed ID: 18313513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs.
    Macedo-Viñas M; De Angelis G; Rohner P; Safran E; Stewardson A; Fankhauser C; Schrenzel J; Pittet D; Harbarth S
    J Hosp Infect; 2013 Jun; 84(2):132-7. PubMed ID: 23608003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden associated with multi-resistant Gram-negative organisms compared with that for methicillin-resistant Staphylococcus aureus in a university teaching hospital.
    Daxboeck F; Budic T; Assadian O; Reich M; Koller W
    J Hosp Infect; 2006 Feb; 62(2):214-8. PubMed ID: 16257092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-acquired methicillin-resistant Staphylococcus aureus infections of the hand: prevalence and timeliness of treatment.
    O'Malley M; Fowler J; Ilyas AM
    J Hand Surg Am; 2009 Mar; 34(3):504-8. PubMed ID: 19258149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.